Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Oaktree Acquisition (OAC) Competitors

OAC vs. TDOC, LFMD, SBC, AUNA, TOI, AIRS, SHLT, CCM, HIMS, and GH

Should you be buying Oaktree Acquisition stock or one of its competitors? The main competitors of Oaktree Acquisition include Teladoc Health (TDOC), LifeMD (LFMD), SBC Medical Group (SBC), Auna (AUNA), Oncology Institute (TOI), AirSculpt Technologies (AIRS), SHL Telemedicine (SHLT), Concord Medical Services (CCM), Hims & Hers Health (HIMS), and Guardant Health (GH).

Oaktree Acquisition vs.

Teladoc Health (NYSE:TDOC) and Oaktree Acquisition (NYSE:OAC) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, community ranking, media sentiment, earnings, dividends and profitability.

Oaktree Acquisition has lower revenue, but higher earnings than Teladoc Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teladoc Health$2.55B0.50-$220.37M-$5.92-1.23
Oaktree AcquisitionN/AN/A$1.15MN/AN/A

In the previous week, Teladoc Health had 17 more articles in the media than Oaktree Acquisition. MarketBeat recorded 17 mentions for Teladoc Health and 0 mentions for Oaktree Acquisition. Teladoc Health's average media sentiment score of 0.62 beat Oaktree Acquisition's score of 0.00 indicating that Teladoc Health is being referred to more favorably in the media.

Company Overall Sentiment
Teladoc Health Positive
Oaktree Acquisition Neutral

Teladoc Health presently has a consensus target price of $9.60, suggesting a potential upside of 31.83%. Given Teladoc Health's stronger consensus rating and higher possible upside, analysts clearly believe Teladoc Health is more favorable than Oaktree Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teladoc Health
0 Sell rating(s)
12 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.37
Oaktree Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Teladoc Health has a beta of 1.78, meaning that its stock price is 78% more volatile than the S&P 500. Comparatively, Oaktree Acquisition has a beta of 0.17, meaning that its stock price is 83% less volatile than the S&P 500.

Teladoc Health received 682 more outperform votes than Oaktree Acquisition when rated by MarketBeat users. However, 100.00% of users gave Oaktree Acquisition an outperform vote while only 62.50% of users gave Teladoc Health an outperform vote.

CompanyUnderperformOutperform
Teladoc HealthOutperform Votes
685
62.50%
Underperform Votes
411
37.50%
Oaktree AcquisitionOutperform Votes
3
100.00%
Underperform Votes
No Votes

Oaktree Acquisition has a net margin of 0.00% compared to Teladoc Health's net margin of -37.91%. Oaktree Acquisition's return on equity of 0.00% beat Teladoc Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Teladoc Health-37.91% -10.06% -4.86%
Oaktree Acquisition N/A N/A N/A

76.8% of Teladoc Health shares are owned by institutional investors. Comparatively, 47.6% of Oaktree Acquisition shares are owned by institutional investors. 0.6% of Teladoc Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Teladoc Health beats Oaktree Acquisition on 10 of the 15 factors compared between the two stocks.

Get Oaktree Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for OAC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OAC vs. The Competition

MetricOaktree AcquisitionOffices & Clinics Of Medical Doctors IndustryMedical SectorNYSE Exchange
Market Cap$1.42B$1.79B$5.52B$19.74B
Dividend YieldN/AN/A5.27%3.85%
P/E RatioN/A27.9027.2435.68
Price / SalesN/A1.74408.5643.36
Price / Cash377.4536.0138.2517.51
Price / Book281.6518.286.974.83
Net Income$1.15M-$52.07M$3.23B$1.02B

Oaktree Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OAC
Oaktree Acquisition
N/A$56.33
+6.7%
N/A+170.9%$1.42BN/A0.00N/AHigh Trading Volume
TDOC
Teladoc Health
3.328 of 5 stars
$7.07
+2.8%
$9.60
+35.8%
-31.6%$1.24B$2.55B-1.225,100Positive News
Gap Down
LFMD
LifeMD
1.5819 of 5 stars
$12.65
-1.6%
$11.00
-13.0%
+68.7%$574.92M$234.01M-19.77230Positive News
SBC
SBC Medical Group
N/A$4.84
+3.4%
N/AN/A$501.48M$197.94M0.00N/APositive News
AUNA
Auna
3.5591 of 5 stars
$6.63
+1.8%
$10.70
+61.4%
-18.9%$490.71M$4.35B11.4314,958Analyst Upgrade
TOI
Oncology Institute
2.2226 of 5 stars
$3.20
-1.5%
$7.00
+118.8%
+517.8%$285.55M$403.15M-4.10660High Trading Volume
AIRS
AirSculpt Technologies
0.8788 of 5 stars
$4.63
+3.8%
$3.75
-19.0%
+17.6%$272.15M$172.10M-33.07240Positive News
SHLT
SHL Telemedicine
N/A$2.05
flat
N/AN/A$33.61M$55.94M0.00583
CCM
Concord Medical Services
1.3263 of 5 stars
$7.23
-5.7%
N/A+1.6%$31.39M$383.96M0.00970
HIMS
Hims & Hers Health
2.4784 of 5 stars
$54.78
-3.5%
$37.67
-31.2%
+171.5%$12.26B$1.78B124.51650Analyst Downgrade
High Trading Volume
GH
Guardant Health
3.9014 of 5 stars
$45.79
+8.8%
$53.29
+16.4%
+67.6%$5.67B$774.00M-12.861,790

Related Companies and Tools


This page (NYSE:OAC) was last updated on 6/9/2025 by MarketBeat.com Staff
From Our Partners